CN1238694A - 治疗肠胃病用的含铋和nsaid的组合物 - Google Patents

治疗肠胃病用的含铋和nsaid的组合物 Download PDF

Info

Publication number
CN1238694A
CN1238694A CN97199982A CN97199982A CN1238694A CN 1238694 A CN1238694 A CN 1238694A CN 97199982 A CN97199982 A CN 97199982A CN 97199982 A CN97199982 A CN 97199982A CN 1238694 A CN1238694 A CN 1238694A
Authority
CN
China
Prior art keywords
bismuth
compositions
nsaid
composition
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97199982A
Other languages
English (en)
Chinese (zh)
Inventor
J·D·考尼茨
O·R·卡赖
田中信
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CN1238694A publication Critical patent/CN1238694A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN97199982A 1996-11-22 1997-11-21 治疗肠胃病用的含铋和nsaid的组合物 Pending CN1238694A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22
US08/755,517 1996-11-22

Publications (1)

Publication Number Publication Date
CN1238694A true CN1238694A (zh) 1999-12-15

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97199982A Pending CN1238694A (zh) 1996-11-22 1997-11-21 治疗肠胃病用的含铋和nsaid的组合物

Country Status (7)

Country Link
EP (1) EP0941102A1 (no)
CN (1) CN1238694A (no)
CA (1) CA2271381A1 (no)
HU (1) HUP9904073A3 (no)
NO (1) NO992468L (no)
TR (1) TR199901101T2 (no)
WO (1) WO1998022118A1 (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425234C (zh) * 2005-06-22 2008-10-15 一洋药品株式会社 用于治疗胃病的含有抗溃疡药和粘膜保护剂的药物组合物
WO2023143573A1 (zh) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 含铋化合物在用于治疗疾病中的用途

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU781133B2 (en) * 1999-02-26 2005-05-05 Nicox S.A. Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
US7285668B2 (en) * 2000-12-01 2007-10-23 Takeda Pharmaceutical Company Limited Process for the crystallization of (R)- or (S)-lansoprazole
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
JP2011513202A (ja) 2008-03-10 2011-04-28 武田薬品工業株式会社 ベンズイミダゾール化合物の結晶
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
WO1993009784A1 (en) * 1991-11-22 1993-05-27 The Procter & Gamble Company Unit dose form of bismuth subsalicylate
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425234C (zh) * 2005-06-22 2008-10-15 一洋药品株式会社 用于治疗胃病的含有抗溃疡药和粘膜保护剂的药物组合物
WO2023143573A1 (zh) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 含铋化合物在用于治疗疾病中的用途

Also Published As

Publication number Publication date
HUP9904073A3 (en) 2000-04-28
HUP9904073A2 (hu) 2000-03-28
WO1998022118A1 (en) 1998-05-28
EP0941102A1 (en) 1999-09-15
NO992468L (no) 1999-07-01
TR199901101T2 (xx) 1999-07-21
NO992468D0 (no) 1999-05-21
CA2271381A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
CN1238694A (zh) 治疗肠胃病用的含铋和nsaid的组合物
Reimer Safety of long-term PPI therapy
Quan et al. Sestrin2 prevents age-related intolerance to post myocardial infarction via AMPK/PGC-1α pathway
WO1998022117A1 (en) Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
Chey et al. Lansoprazole and Ranitidine Affect the Accuracy of the 14 C-Urea Breath Test by a pH-Dependent Mechanism.
Borrero et al. Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically III
Spirt et al. Update on stress ulcer prophylaxis in critically ill patients
JP2648327B2 (ja) 胃腸疾患を治療するための組成物及び方法
JP6366548B2 (ja) 胃酸分泌の即効性阻害剤
Marks et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis
Bresalier et al. Sucralfate suspension versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients
US4968716A (en) Compositions and methods for administering therapeutically active compounds
PT1096932E (pt) ''combinação anti-hipertensiva de valsartan e bloqueadores do canal de cálcio''
Moon et al. Acute endosulfan poisoning: a retrospective study
WO1984003623A1 (en) Pharmaceutical compositions
Carroccio et al. Domperidone plus magnesium hydroxide and aluminum hydroxide: a valid therapy in children with gastroesophageal reflux: a double-blind randomized study versus placebo
Salmon et al. Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up
Geus et al. Prevention of stress ulcer bleeding: a review
Van Den Berg et al. Prevention of stress-induced upper gastrointestinal bleeding by cimetidine in patients on assisted ventilation
Heller et al. Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.
PL118528B1 (en) Process for the production of alkali metals acid citrates
RU2059410C1 (ru) Терапевтическая композиция
Ozalp et al. Evaluation of risk factors for mortality in perforated peptic ulcer in Ankara Numune Teaching Hospital, Ankara, Turkey
JP2005524604A (ja) 活性炭を含有する経口製剤及びその用途
CN117919240A (zh) 一种治疗血管钙化的药物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication